Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Understanding which risk dominates can guide your allocation decisions. This comparison highlights when inflation worry or market dips matter more.
28,524 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Stellantis unveiled a bold €60 billion turnaround plan at Investor Day, aiming to reshape costs, cash flow, and a mod...
Goldman Sachs names Marvell Technology and Micron Technology as the linchpins of the next AI deployment cycle, elevat...
Accenture posted solid earnings but offered a cautious outlook, prompting a market selloff. Analysts point to two mai...
As volatility returns to the markets in May 2026, active and beginner investors alike seek affordable, feature-rich p...
BBB Foods reports Q1 2026 results with modest revenue growth and steadier margins. This review translates the transcr...
Through mid-May 2026, VXUS has risen about 10% year-to-date, narrowly surpassing the S&P 500’s roughly 8% gain. The m...
A dynamic withdrawal sequence across a 401(k), Roth IRA, and brokerage saved a couple hundreds of thousands in lifeti...
Dell Technologies leads the pack in 2026 among AI server stocks, outpacing Hewlett Packard Enterprise and Super Micro...
Qualcomm is betting big on non-phone AI devices, teaming with top AI firms to power wearables that act as autonomous ...
CoreWeave’s stock suffers another long selloff as investors weigh debt exposure against growth in the AI cloud market...
A lithium-tech startup has reached unicorn status with a $1 billion valuation as demand for lithium accelerates acros...